INS and liver dysplastic nodule: Although the level of insulin (Figure 2H) was not significantly increased by the YSHS, both HbA1c (Figure 2E) and C-peptide (Figure 2I) were ameliorated by the drug, suggesting YSHS possessed beneficial effects against insulin resistance in DN.